In the bi-variable analysis, eleven variables (occupation, WHO clinical stage, nutritional status, CD4 count, opportunistic infection, disclosure status, enrollment type, ART drug adherence, drug side effect, anemia, and isoniazid preventive therapy) were found to be associated at a P-value of 0.2. Here, CD4 is linked to anemia.